Anne Margrete Øyan, Ph.D., is a Senior Scientist at the Department of Clinical Science, University of Bergen, Bergen. She completed her Ph.D. on the herpes simplex virus (HSV-1) and its interaction with the cellular receptor at the Department of Infectious Diseases and the Department of Hematology, Beth Israel Hospital, Harvard Medical School, Boston, USA. Currently she is involved in a drug discovery and development program and a translational and clinical trial project of cancer immunotherapy at the Department of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen.
Anne Margrete Øyan, Ph.D., is a Senior Scientist at the Department of Clinical Science, University of Bergen, Bergen. She completed her Ph.D. on the herpes simplex virus (HSV-1) and its interaction with the cellular receptor at the Department of Infectious Diseases and the Department of Hematology, Beth Israel Hospital, Harvard Medical School, Boston, USA. Currently she is involved in a drug discovery and development program and a translational and clinical trial project of cancer immunotherapy at the Department of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen.